CRI Anna-Maria Kellen Clinical Accelerator and Venture Fund Managing Director Jay Campbell will moderate a panel titled, “Oncology: Moving Faster and Smarter to Improve Patient Outcomes” on accelerating cancer therapeutics development on January 9, 2023. Panelists include Stacy Blain, CEO of Concarlo Therapeutics, Michael Goldberg, CEO of Surge Therapeutics, and Crystal Mackall, professor of pediatrics and medicine at Stanford University.
CRI Speaks: Biotech Showcase 2023
Stay up to date
Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.
